These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2302789)

  • 1. Dextromethorphan oxidation phenotypes as markers for susceptibility to lung cancer.
    Faccini GB; Puchetti V; Zatti N
    Clin Chem; 1990 Feb; 36(2):387. PubMed ID: 2302789
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextromethorphan phenotypes determined by high-performance liquid chromatography and fluorescence detection.
    Jacqz-Aigrain E; Menard Y; Popon M; Mathieu H
    J Chromatogr; 1989 Oct; 495():361-3. PubMed ID: 2613825
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphism of dextromethorphan oxidation in a French population.
    Larrey D; Amouyal G; Tinel M; Letteron P; Berson A; Labbe G; Pessayre D
    Br J Clin Pharmacol; 1987 Nov; 24(5):676-9. PubMed ID: 3435696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary metabolism of dextromethorphan in man.
    Köppel C; Tenczer J; Ibe K
    Arzneimittelforschung; 1987 Nov; 37(11):1304-6. PubMed ID: 3440042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.
    Larrey D; Babany G; Tinel M; Freneaux E; Amouyal G; Habersetzer F; Letteron P; Pessayre D
    Br J Clin Pharmacol; 1989 Sep; 28(3):297-304. PubMed ID: 2789923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The urinary excretion of dextromethorphan and three metabolites in dogs and humans.
    Barnhart JW
    Toxicol Appl Pharmacol; 1980 Aug; 55(1):43-8. PubMed ID: 7423506
    [No Abstract]   [Full Text] [Related]  

  • 7. Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.
    Belec L; Larrey D; De Cremoux H; Tinel M; Louarn F; Pessayre D; Gherardi R
    Br J Clin Pharmacol; 1989 Mar; 27(3):387-90. PubMed ID: 2719897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin.
    Baumann P; Jonzier-Perey M
    Clin Chim Acta; 1988 Feb; 171(2-3):211-22. PubMed ID: 3370821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.
    Henthorn TK; Benitez J; Avram MJ; Martinez C; Llerena A; Cobaleda J; Krejcie TC; Gibbons RD
    Clin Pharmacol Ther; 1989 Mar; 45(3):328-33. PubMed ID: 2920506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up.
    Motassim N; Decolin D; Le Dinh T; Nicolas A; Siest G
    J Chromatogr; 1987 Nov; 422():340-5. PubMed ID: 3437023
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.
    Schmid B; Bircher J; Preisig R; Küpfer A
    Clin Pharmacol Ther; 1985 Dec; 38(6):618-24. PubMed ID: 4064464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.
    Evans WE; Relling MV; Petros WP; Meyer WH; Mirro J; Crom WR
    Clin Pharmacol Ther; 1989 May; 45(5):568-73. PubMed ID: 2721111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.
    Guttendorf RJ; Britto M; Blouin RA; Foster TS; John W; Pittman KA; Wedlund PJ
    Br J Clin Pharmacol; 1990 Apr; 29(4):373-80. PubMed ID: 2328190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified phenotyping with dextromethorphan by thin-layer chromatography: application to clinical laboratory screening for deficiencies in oxidative drug metabolism.
    Guttendorf RJ; Wedlund PJ; Blake J; Chang SL
    Ther Drug Monit; 1988; 10(4):490-8. PubMed ID: 3201536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan phenotypes in paediatric patients with autoimmune hepatitis.
    Jacqz-Aigrain E; Laurent J; Alvarez F
    Br J Clin Pharmacol; 1990 Jul; 30(1):153-4. PubMed ID: 2390427
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of dextromethorphan and metabolites in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    East T; Dye D
    J Chromatogr; 1985 Feb; 338(1):99-112. PubMed ID: 4019660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.
    Küpfer A; Schmid B; Preisig R; Pfaff G
    Lancet; 1984 Sep; 2(8401):517-8. PubMed ID: 6147572
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes.
    Broly F; Libersa C; Lhermitte M; Dupuis B
    Biochem Pharmacol; 1990 Mar; 39(6):1045-53. PubMed ID: 2322292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T; Zeugin T; Küpfer A
    Biochem Pharmacol; 1988 Aug; 37(16):3155-60. PubMed ID: 3401246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism.
    Roy SD; Hawes EM; Hubbard JW; McKay G; Midha KK
    Lancet; 1984 Dec; 2(8416):1393. PubMed ID: 6150386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.